JP2015533174A5 - - Google Patents

Download PDF

Info

Publication number
JP2015533174A5
JP2015533174A5 JP2015536950A JP2015536950A JP2015533174A5 JP 2015533174 A5 JP2015533174 A5 JP 2015533174A5 JP 2015536950 A JP2015536950 A JP 2015536950A JP 2015536950 A JP2015536950 A JP 2015536950A JP 2015533174 A5 JP2015533174 A5 JP 2015533174A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
core
weight
composition according
lubricant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015536950A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015533174A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/064596 external-priority patent/WO2014059309A1/en
Publication of JP2015533174A publication Critical patent/JP2015533174A/ja
Publication of JP2015533174A5 publication Critical patent/JP2015533174A5/ja
Pending legal-status Critical Current

Links

JP2015536950A 2012-10-11 2013-10-11 ピロカルピンの医薬製剤 Pending JP2015533174A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261712784P 2012-10-11 2012-10-11
US61/712,784 2012-10-11
PCT/US2013/064596 WO2014059309A1 (en) 2012-10-11 2013-10-11 Pharmaceutical formulations of pilocarpine

Publications (2)

Publication Number Publication Date
JP2015533174A JP2015533174A (ja) 2015-11-19
JP2015533174A5 true JP2015533174A5 (cg-RX-API-DMAC7.html) 2016-12-01

Family

ID=50475520

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015536950A Pending JP2015533174A (ja) 2012-10-11 2013-10-11 ピロカルピンの医薬製剤

Country Status (5)

Country Link
US (1) US20140105976A1 (cg-RX-API-DMAC7.html)
JP (1) JP2015533174A (cg-RX-API-DMAC7.html)
KR (1) KR20150068460A (cg-RX-API-DMAC7.html)
CA (1) CA2885979A1 (cg-RX-API-DMAC7.html)
WO (1) WO2014059309A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2479213B (en) 2010-04-01 2013-07-10 Theravida Inc Pharmaceutical formulations for the treatment of overactive bladder
MX348723B (es) 2011-05-10 2017-06-27 Theravida Inc Combinaciones de solifenacina y estimulantes salivales para el tratamiento de la vejiga hiperactiva.
EP3405191B1 (en) 2016-01-20 2025-02-19 TheraVida, Inc. Compositions for use in treating hyperhidrosis
AU2019214557A1 (en) * 2018-02-05 2020-08-20 Cellixbio Private Limited Combination of an antimuscarinic or an anticholinergic agent and lipoic acid and uses thereof
EP3740240A4 (en) * 2018-02-19 2021-07-28 Sensient Colors LLC COMPOSITIONS FOR THE COATING OF EDIBLE SUBSTRATES AND THEIR MANUFACTURING AND USE PROCESSES

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003082207A2 (en) * 2002-03-29 2003-10-09 Alza Corporation Volume efficient controlled release dosage form
AR045957A1 (es) * 2003-10-03 2005-11-16 Novartis Ag Composicion farmaceutica y combinacion
US20080254115A1 (en) * 2004-05-19 2008-10-16 Rubino Orapin P Micropellet Containing Pellets and Method of Preparing Such Pellets
AU2005285298A1 (en) * 2004-08-27 2006-03-23 Spherics, Inc. Multi-layer tablets and bioadhesive dosage forms
JP2008516893A (ja) * 2004-08-27 2008-05-22 スフェリックス,インク. 多層錠剤および生体接着性剤形
GB2479213B (en) * 2010-04-01 2013-07-10 Theravida Inc Pharmaceutical formulations for the treatment of overactive bladder

Similar Documents

Publication Publication Date Title
JP2011510024A5 (cg-RX-API-DMAC7.html)
JP2015533174A5 (cg-RX-API-DMAC7.html)
JP6084161B2 (ja) 7−[4−(4−ベンゾ[b]チオフェン−4−イル−ピペラジン−1−イル)ブトキシ]−1H−キノリン−2−オン又はその塩を含む錠剤
FI3182975T3 (fi) Rukaparibin suuren annosvahvuuden tabletteja
NZ602075A (en) Abuse-resistant formulations
JP2013522373A5 (cg-RX-API-DMAC7.html)
JP2008501025A5 (cg-RX-API-DMAC7.html)
JP2017525712A5 (cg-RX-API-DMAC7.html)
JP2014167026A5 (cg-RX-API-DMAC7.html)
JP2011098964A5 (cg-RX-API-DMAC7.html)
HRP20161210T4 (hr) Formulacija obložene tablete i postupak
JP2015509539A5 (cg-RX-API-DMAC7.html)
JP2005538104A5 (cg-RX-API-DMAC7.html)
JP2011503048A5 (cg-RX-API-DMAC7.html)
HRP20192065T1 (hr) Čvrsti oblici doziranja palbocikliba
PH12015502134A1 (en) Mosapride sustained-release preparation for providing pharmacological and clinical effects with once-a-day administration
HRP20240564T1 (hr) Novi farmaceutski sastav
HRP20161262T1 (hr) Tablete ulipristal acetata
JP2020530832A5 (cg-RX-API-DMAC7.html)
WO2013084089A1 (en) Methods for treating cardiovascular disorder
JP2019513800A5 (cg-RX-API-DMAC7.html)
JP2015510916A5 (cg-RX-API-DMAC7.html)
JP2007182451A5 (cg-RX-API-DMAC7.html)
JP2016508996A5 (cg-RX-API-DMAC7.html)
JP2016530238A5 (cg-RX-API-DMAC7.html)